AKBA fundamentals
Akebia Therapeutics, Inc. earnings per share and revenue
AKBA earnings per share for the last quarter are -0.10 USD whereas the estimation was -0.08 USD which accounts for -23.87% surprise. Company revenue for the same period amounts to 46.50 M USD despite the estimated figure of 37.34 M USD. Estimated earnings per share for the next quarter are -0.05 USD, and revenue is expected to reach 44.38 M USD. Also watch annual changes over time to get a bigger picture of AKBA earnings per share and revenue dynamics.
Next report date
≈
Report periodQ1 2025
EPS estimate−0.05USD
Revenue estimate44.38 MUSD
EPS
Forecast
Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Q4 '25
−0.16
−0.12
−0.08
−0.04
0.00
Reported
Estimate
Currency: USD
Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Reported
−0.14
−0.06
−0.08
0.00
−0.09
−0.04
−0.10
−0.10
—
—
—
—
Estimate
−0.14
−0.03
−0.09
−0.04
−0.07
−0.07
−0.06
−0.08
−0.05
−0.06
−0.06
−0.05
Surprise
+3.45%
−140.00%
+5.88%
+100.00%
−25.06%
+44.64%
−57.90%
−23.87%
—
—
—
—
Revenue
Forecast
Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Q4 '25
0.00
15.00 M
30.00 M
45.00 M
60.00 M
Reported
Estimate
Currency: USD
Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Reported
40.13 M
56.38 M
42.00 M
56.20 M
32.61 M
43.60 M
37.43 M
46.50 M
—
—
—
—
Estimate
46.68 M
59.10 M
48.18 M
55.39 M
46.09 M
49.80 M
44.50 M
37.34 M
44.38 M
44.13 M
49.40 M
55.85 M
Surprise
−14.05%
−4.61%
−12.83%
+1.45%
−29.25%
−12.45%
−15.89%
+24.52%
—
—
—
—